Glutathione doesn't just fight on its own
465 From a more novel perspective, the findings that intralesional oncolytic herpes virus treatment enhances anticancer immune responses in immunosuppressive tumor microenvironments provide a biological rationale for the use of this oncolytic modality in cancers that are otherwise unresponsive to immunotherapy
Key Takeaways: BPC-157 vs TB-500 BPC-157 is a localized repair peptide: derived from a protective protein in gastric juice, it promotes angiogenesis and collagen synthesis at the injection site, making it most effective when the injury is identifiable and accessible
After that, it begins a slow, steady decline
It's very powerful, according to experts
These transcriptomic alterations suggest that hypoxia is associated with changes in oxygen sensing and metabolic adaptation in USCs, while the functional relevance of these changes requires further validation